Passeo-18 3/120/130Recalls & reported problems
Biotronik AG · Class 2
All models of Passeo-18 (54)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 07640119559193), received between Aug 6, 2019 and Jan 29, 2026 — classified as 6 malfunctions.
The most frequently reported specific device problem is “Material Rupture” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Material Rupture3
- Material Puncture/Hole2
- Fluid/Blood Leak1
- Leak/Splash1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 29, 2026Material Puncture/Hole; Material Rupture
THE PASSEO-18 PERIPHERAL BALLOON CATHETER WAS SELECTED FOR TREATMENT OF THE PROXIMAL ANTERIOR TIBIAL ARTERY. THE DEVICE WAS INTRODUCED FOR AN ANGIOPLASTY PROCEDURE, BUT IT BURST BEFORE REACHING NOMINAL PRESSURE. THE BURST BALLOON WAS REMOVED AND REPLACED BY A BALLOON FROM ANOTHER COMPANY, WHICH WAS SUCCESSFULLY INFLATED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24209608 ↗MalfunctionApr 14, 2025Material Rupture; Material Rupture
DURING THE PASSAGE OF THE PASSEO-18 PERIPHERAL DILATION CATHETER, THE BALLOON WAS INTRODUCED INTO A PRE-DILATED MILDLY CALCIFIED LESION IN THE POSTERIOR TIBIAL ARTERY. HOWEVER, AT A PRESSURE OF 10 ATM, THE BALLOON RUPTURED. THE DEVICE WAS WITHDRAWN, NO PART REMAINED IN PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21836997 ↗MalfunctionMar 20, 2025Fluid/Blood Leak; Fluid/Blood Leak
THE PASSEO-18 PERIPHERAL BALLOON CATHETER WAS SELECTED FOR TREATMENT OF A MILDLY CALCIFIED LESION (70 PERCENT STENOSIS DEGREE) IN A MILDLY TORTUOUS PART OF THE MID POPLITEAL ARTERY. IT WAS NOT POSSIBLE TO INFLATE THE BALLOON. AFTER WITHDRAWAL OF THE DEVICE A LEAKAGE OF THE BALLOON WAS DETECTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21655331 ↗MalfunctionMay 1, 2024Material Puncture/Hole; Material Puncture/Hole
A PASSEO-18 PERIPHERAL BALLOON CATHETER WAS SELECTED FOR TREATMENT OF A MODERATELY CALCIFIED LESION (STENOSIS DEGREE: 50 PERCENT) IN THE MODERATELY TORTUOUS POSTERIOR TIBIAL ARTERY (PTA). THE PASSEO-18 WAS INFLATED AT THE PTA LESION AT 6 ATM. HOWEVER, AS THE BALLOON WAS INFLATING, IT WAS OBSERVED THAT BLOOD WAS FLOWING INTO THE INFLATION DEVICE. IT WAS SUSPECTED THAT THE BALLOON WAS RUPTURED BUT THE BALLOON WAS ABLE TO INFLATE AND MAINTAINED AT 6 ATM EVEN THOUGH BLOOD CONTINUE TO FLOW INTO THE INFLATION DEVICE. THE BALLOON WAS DEFLATED AND REMOVED FROM THE PATIENT WITHOUT DIFFICULTIES. A NEW BALLOON WAS USED AND THE LESION SUCCESSFULLY DILATED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19219900 ↗MalfunctionJan 21, 2021Material Rupture; Material Rupture
A PASSEO 18 BALLOON CATHETER WAS CHOSEN FOR TREATMENT OF A MODERATELY CALCIFIED LESION (70 PERCENT STENOSIS DEGREE) IN A MILDLY TORTUOUS ULNAR ARTERY. DURING INFLATION AT NOMINAL PRESSURE, THE BALLOON BURST.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11209195 ↗MalfunctionAug 6, 2019Leak/Splash; Leak/Splash
THE PASSEO-18 BALLOON CATHETER WAS SELECTED FOR USE. AFTER UNPACKING THE DOCTOR INJECTED THE BALLOON WITH HEPARINIZED SALINE TO FLUSH. THEREBY IT WAS NOTED THAT THE LUMEN COULD NOT BE FLUSHED PROPERLY AND A LEAKAGE WAS DETECTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8866651 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page